Cargando…
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer
Breast cancer (BC) is a major health burden that affects over one million women each year. It is the most prevalent cancer in women and the number one cancer killer of them worldwide. Of all BC subtypes, estrogen receptor-positive (ER+) BC is the most commonly diagnosed. The objective of this study...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946945/ https://www.ncbi.nlm.nih.gov/pubmed/35328298 http://dx.doi.org/10.3390/diagnostics12030745 |
_version_ | 1784674316365856768 |
---|---|
author | Msheik, Zahraa S. Nassar, Farah J. Chamandi, Ghada Itani, Abdul Rahman Gadaleta, Emanuala Chalala, Claude Alwan, Nisreen Nasr, Rihab R. |
author_facet | Msheik, Zahraa S. Nassar, Farah J. Chamandi, Ghada Itani, Abdul Rahman Gadaleta, Emanuala Chalala, Claude Alwan, Nisreen Nasr, Rihab R. |
author_sort | Msheik, Zahraa S. |
collection | PubMed |
description | Breast cancer (BC) is a major health burden that affects over one million women each year. It is the most prevalent cancer in women and the number one cancer killer of them worldwide. Of all BC subtypes, estrogen receptor-positive (ER+) BC is the most commonly diagnosed. The objective of this study is to investigate the contribution of miR-126 in the tumorigenesis of ER+ BC. miR-126 was downregulated in ER+ BC tissues from young breast cancer patients, as shown through miRNA microarray analysis and RT-qPCR. Subsequently, the effect of the modulation of miR-126 levels on the proliferation, cell cycle progression, and spheres formation of the ER+ BC cell line, MCF-7, was assessed by MTT assay, PI analysis, and mammosphere formation assay, respectively. miR-126 overexpression significantly decreased MCF-7 proliferation and mammosphere-forming ability, but did not affect cell cycle progression. Then, in silico analysis determined SLC7A5, PLXNB2, CRK, PLK2, SPRED1, and IRS1 as potential targets of miR-126. RT-qPCR data showed that miR-126 overexpression significantly downregulated SLC7A5 and PLXNB2 mRNA levels in MCF-7. Finally, in silico survival analysis showed that high expression of miR-126 or low expression of SLC7A5 correlated with better overall survival (OS) of ER+ BC patients. Overall, our study suggests that miR-126 might play a tumor suppressor role in ER+ BC. miR-126 and SLC7A5 might also be considered potential prognostic biomarkers in ER+ BC. |
format | Online Article Text |
id | pubmed-8946945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89469452022-03-25 miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer Msheik, Zahraa S. Nassar, Farah J. Chamandi, Ghada Itani, Abdul Rahman Gadaleta, Emanuala Chalala, Claude Alwan, Nisreen Nasr, Rihab R. Diagnostics (Basel) Article Breast cancer (BC) is a major health burden that affects over one million women each year. It is the most prevalent cancer in women and the number one cancer killer of them worldwide. Of all BC subtypes, estrogen receptor-positive (ER+) BC is the most commonly diagnosed. The objective of this study is to investigate the contribution of miR-126 in the tumorigenesis of ER+ BC. miR-126 was downregulated in ER+ BC tissues from young breast cancer patients, as shown through miRNA microarray analysis and RT-qPCR. Subsequently, the effect of the modulation of miR-126 levels on the proliferation, cell cycle progression, and spheres formation of the ER+ BC cell line, MCF-7, was assessed by MTT assay, PI analysis, and mammosphere formation assay, respectively. miR-126 overexpression significantly decreased MCF-7 proliferation and mammosphere-forming ability, but did not affect cell cycle progression. Then, in silico analysis determined SLC7A5, PLXNB2, CRK, PLK2, SPRED1, and IRS1 as potential targets of miR-126. RT-qPCR data showed that miR-126 overexpression significantly downregulated SLC7A5 and PLXNB2 mRNA levels in MCF-7. Finally, in silico survival analysis showed that high expression of miR-126 or low expression of SLC7A5 correlated with better overall survival (OS) of ER+ BC patients. Overall, our study suggests that miR-126 might play a tumor suppressor role in ER+ BC. miR-126 and SLC7A5 might also be considered potential prognostic biomarkers in ER+ BC. MDPI 2022-03-18 /pmc/articles/PMC8946945/ /pubmed/35328298 http://dx.doi.org/10.3390/diagnostics12030745 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Msheik, Zahraa S. Nassar, Farah J. Chamandi, Ghada Itani, Abdul Rahman Gadaleta, Emanuala Chalala, Claude Alwan, Nisreen Nasr, Rihab R. miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title_full | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title_fullStr | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title_full_unstemmed | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title_short | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer |
title_sort | mir-126 decreases proliferation and mammosphere formation of mcf-7 and predicts prognosis of er+ breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946945/ https://www.ncbi.nlm.nih.gov/pubmed/35328298 http://dx.doi.org/10.3390/diagnostics12030745 |
work_keys_str_mv | AT msheikzahraas mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT nassarfarahj mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT chamandighada mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT itaniabdulrahman mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT gadaletaemanuala mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT chalalaclaude mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT alwannisreen mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer AT nasrrihabr mir126decreasesproliferationandmammosphereformationofmcf7andpredictsprognosisoferbreastcancer |